Last Updated on January 8, 2021 by The Health Master
The vaccine will be sold at a higher price of Rs 1,000 per dose to private buyers.
The Oxford University-AstraZeneca vaccine was granted emergency authorisation by the Indian regulator on Sunday.
The authorization was granted on the condition that Serum Institute doesn’t export the shots, to ensure the safety of the vulnerable populations in India.
Watch the video for more:
Also read | Masks probably may never even go: ICMR
Go to main website, click here
Subscribe for daily free updates, click here